Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.30 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.30 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1900465 | 1.00 | THRB (0.32) | THRBLMNATDP1SPHK2SPHK1 | |
| SCHEMBL30057341 | 1.00 | THRB (0.32) | THRBLMNATDP1SPHK2SPHK1 | |
| SCHEMBL3296001 | 1.00 | THRB (0.32) | THRBLMNATDP1SPHK2SPHK1 | |
| SCHEMBL18856153 | 1.00 | THRB (0.32) | THRBLMNATDP1SPHK2SPHK1 | |
| SCHEMBL1900467 | 1.00 | THRB (0.32) | THRBLMNATDP1SPHK2SPHK1 | |
| SCHEMBL10015241 | 1.00 | THRB (0.32) | THRBLMNATDP1SPHK2SPHK1 | |
| SCHEMBL16994826 | 1.00 | THRB (0.32) | THRBLMNATDP1SPHK2SPHK1 | |
| SCHEMBL28627915 | 1.00 | THRB (0.32) | THRBLMNATDP1SPHK2SPHK1 | |
| Tetrahydrofuran SCHEMBL29115159 | 0.89 | — | — | |
| SCHEMBL13312833 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117700388-A | Synthesis method of high-quality (beta, S) -configuration hydroxypropyl tetrahydropyran triol | 青岛巽田科技有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-113416756-B | Method for synthesizing hydroxypropyl tetrahydropyran triol catalyzed by biological enzyme | 上海克琴科技有限公司 | 2023-10-31 | — | — | CN | disclosed |
| WO-2023077817-A1 | ENZYME COMPOSITION AND METHOD FOR SYNTHESIZING PRO-XYLANE BY USING CHEMICAL ENZYMATIC METHOD | 深圳瑞德林生物技术有限公司 | 2023-05-11 | — | — | WO | disclosed |
| CN-113416756-A | Method for synthesizing hydroxypropyl tetrahydropyrane triol catalyzed by biological enzyme | 上海克琴科技有限公司 | 2021-09-21 | — | — | CN | disclosed |
| US-9096630-B2 | Amphiphilic compositions and methods for preparing and using same | YALE UNIVERSITY (US) | 2015-08-04 | — | — | US | disclosed |
| US-9096630-B2 | Amphiphilic compositions and methods for preparing and using same | YALE UNIVERSITY (US) | 2015-08-04 | — | — | US | disclosed |
| EP-1345919-B1 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | OREAL (FR) | 2013-05-22 | — | — | EP | disclosed |
| US-20120225832-A1 | Amphiphilic Compositions and Methods for Preparing and Using Same | YALE UNIVERSITY (US) | 2012-09-06 | — | — | US | disclosed |
| US-20120225832-A1 | Amphiphilic Compositions and Methods for Preparing and Using Same | YALE UNIVERSITY (US) | 2012-09-06 | — | — | US | disclosed |
| WO-2011057192-A2 | AMPHIPHILIC COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME | YALE UNIVERSITY (US) | 2011-05-12 | — | — | WO | disclosed |
| US-7732414-B2 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL S.A. (FR) | 2010-06-08 | — | — | US | disclosed |
| US-20060223763-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL S.A. (FR) | 2006-10-05 | — | — | US | disclosed |
| US-7049300-B2 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL (FR) | 2006-05-23 | — | — | US | disclosed |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | SOCIETE L'OREAL S.A. (FR) | 2004-03-11 | — | — | US | disclosed |
| EP-1345919-A2 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | L'OREAL (FR) | 2003-09-24 | — | — | EP | disclosed |
| WO-2002051828-A2 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | L'OREAL (FR) | 2002-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223763-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | CSGALNACT1, FUT6, AREG | THRB 2233/4885LMNA 2083/4885TDP1 4673/4885 |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | CSGALNACT1, FUT6, AREG | THRB 2233/4885LMNA 2083/4885TDP1 4673/4885 |
| US-20120225832-A1 | Amphiphilic Compositions and Methods for Preparing and Using Same | UGCG, SGMS2, SGMS1 | THRB 4845/4885LMNA 266/4885TDP1 4333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.